Cardiovascular Medicine Faculty
William P. Fay, M.D., F.A.C.C., F.A.H.A
J.W. and Lois Winifred Stafford Distinguished Chair in Diabetes and Cardiovascular Research
Professor of Internal Medicine, Pharmacology & Physiology
Director, Division of Cardiology
Dr. Fay’s primary areas of interest are adult heart disease, anticoagulation, thrombosis, and atherosclerosis.
Lab Website
Board Certifications:
- Internal Medicine
- Cardiovascular Disease
Professional Society Memberships:
- American Heart Association
- American College of Cardiology
- International Society on Thrombosis and Haemostasis
- Central Society for Clinical Research
- American Society of Hematology
Medical School
University of Illinois-ChicagoResidency
Internal Medicine
University of Michigan
Fellowship
Cardiovascular Disease
Mayo ClinicRecent Publications
- Filippov S, Koenig GC, Chun T-H, Hotary KB, Ota I, Bugge TH, Roberts JD, Fay WP, Birkedal-Hansen H, Holmbeck K, Sabeh F, Allen ED, Weiss SJ: MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J. Exp. Med. 2005; 202:663-671.
- Day SM, Reeve JL, Pedersen, B, Farris DM, Myers DD, Im M, Wakefield TW, Mackman N, Fay WP: Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005;105:192-198.
- Sun H, Ringdahl U, Homeister J, Fay WP, Engleberg C, Yang A, Wang X, Sjobring U, Ginsburg D: Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004;305:1283-1286.
- Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G, Fay WP, Sullenger BA: Antidote-mediated control of anticoagulant aptamer activity in vivo. Nature Biotechnology 2004;22:1423-1428.
- Parker AC, Mundada LV, Schmaier AH, Fay WP: Factor VLeiden inhibits fibrinolysis in vivo. Circulation 2004;110:3594-3598.
